Cargando…

Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium

Mammalian target of rapamycin (mTOR) is involved in insulin resistance (IR) and diabetic retinopathy. In retinal pigment epithelial (RPE) cells, insulin activates the mTOR pathway, inducing hypoxia-inducible factor-1α (HIF-1α) and HIF-dependent transcription in serum-free minimum essential medium Ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Leontieva, O V, Demidenko, Z N, Blagosklonny, M V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047870/
https://www.ncbi.nlm.nih.gov/pubmed/24810050
http://dx.doi.org/10.1038/cddis.2014.178
_version_ 1782480451548479488
author Leontieva, O V
Demidenko, Z N
Blagosklonny, M V
author_facet Leontieva, O V
Demidenko, Z N
Blagosklonny, M V
author_sort Leontieva, O V
collection PubMed
description Mammalian target of rapamycin (mTOR) is involved in insulin resistance (IR) and diabetic retinopathy. In retinal pigment epithelial (RPE) cells, insulin activates the mTOR pathway, inducing hypoxia-inducible factor-1α (HIF-1α) and HIF-dependent transcription in serum-free minimum essential medium Eagle (MEM). Serendipitously, we found that insulin failed to induce the HIF-1α-dependent response, when RPE cells were cultured in Dulbecco's modification of Eagle's medium (DMEM). Whereas concentration of glucose in MEM corresponds to normal glucose levels in blood (5.5 mM), its concentration in DMEM corresponds to severe diabetic hyperglycemia (25 mM). Addition of glucose to MEM also caused IR. Glucose-mediated IR was characterized by basal activation of mTORC1 and its poor inducibility by insulin. Basal levels of phosphorylated S6 kinase (S6K), S6 and insulin receptor substrate 1 (IRS1) S635/639 were high, whereas their inducibilities were decreased. Insulin-induced Akt phosphorylation was decreased and restored by rapamycin and an inhibitor of S6K. IR was associated with de-phosphorylation of IRS1 at S1011, which was reversed by rapamycin. Both short (16–40 h) and chronic (2 weeks) treatment with rapamycin reversed IR. Furthermore, rapamycin did not impair Akt activation in RPE cells cultured in normoglycemic media. In contrast, Torin 1 blocked Akt activation by insulin. We conclude that by activating mTOR/S6K glucose causes feedback IR, preventable by rapamycin. Rapamycin does not cause IR in RPE cells regardless of the duration of treatment. We confirmed that rapamycin also did not impair phosphorylation of Akt at T308 and S473 in normal myoblast C2C12 cells. Our work provides insights in glucose-induced IR and suggests therapeutic approaches to treat patients with IR and severe hyperglycemia and to prevent diabetic complications such as retinopathy. Also our results prompt to reconsider physiological relevance of numerous data and paradigms on IR given that most cell lines are cultured with grossly super-physiological levels of glucose.
format Online
Article
Text
id pubmed-4047870
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-40478702014-06-12 Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium Leontieva, O V Demidenko, Z N Blagosklonny, M V Cell Death Dis Original Article Mammalian target of rapamycin (mTOR) is involved in insulin resistance (IR) and diabetic retinopathy. In retinal pigment epithelial (RPE) cells, insulin activates the mTOR pathway, inducing hypoxia-inducible factor-1α (HIF-1α) and HIF-dependent transcription in serum-free minimum essential medium Eagle (MEM). Serendipitously, we found that insulin failed to induce the HIF-1α-dependent response, when RPE cells were cultured in Dulbecco's modification of Eagle's medium (DMEM). Whereas concentration of glucose in MEM corresponds to normal glucose levels in blood (5.5 mM), its concentration in DMEM corresponds to severe diabetic hyperglycemia (25 mM). Addition of glucose to MEM also caused IR. Glucose-mediated IR was characterized by basal activation of mTORC1 and its poor inducibility by insulin. Basal levels of phosphorylated S6 kinase (S6K), S6 and insulin receptor substrate 1 (IRS1) S635/639 were high, whereas their inducibilities were decreased. Insulin-induced Akt phosphorylation was decreased and restored by rapamycin and an inhibitor of S6K. IR was associated with de-phosphorylation of IRS1 at S1011, which was reversed by rapamycin. Both short (16–40 h) and chronic (2 weeks) treatment with rapamycin reversed IR. Furthermore, rapamycin did not impair Akt activation in RPE cells cultured in normoglycemic media. In contrast, Torin 1 blocked Akt activation by insulin. We conclude that by activating mTOR/S6K glucose causes feedback IR, preventable by rapamycin. Rapamycin does not cause IR in RPE cells regardless of the duration of treatment. We confirmed that rapamycin also did not impair phosphorylation of Akt at T308 and S473 in normal myoblast C2C12 cells. Our work provides insights in glucose-induced IR and suggests therapeutic approaches to treat patients with IR and severe hyperglycemia and to prevent diabetic complications such as retinopathy. Also our results prompt to reconsider physiological relevance of numerous data and paradigms on IR given that most cell lines are cultured with grossly super-physiological levels of glucose. Nature Publishing Group 2014-05 2014-05-08 /pmc/articles/PMC4047870/ /pubmed/24810050 http://dx.doi.org/10.1038/cddis.2014.178 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Article
Leontieva, O V
Demidenko, Z N
Blagosklonny, M V
Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
title Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
title_full Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
title_fullStr Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
title_full_unstemmed Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
title_short Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
title_sort rapamycin reverses insulin resistance (ir) in high-glucose medium without causing ir in normoglycemic medium
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047870/
https://www.ncbi.nlm.nih.gov/pubmed/24810050
http://dx.doi.org/10.1038/cddis.2014.178
work_keys_str_mv AT leontievaov rapamycinreversesinsulinresistanceirinhighglucosemediumwithoutcausingirinnormoglycemicmedium
AT demidenkozn rapamycinreversesinsulinresistanceirinhighglucosemediumwithoutcausingirinnormoglycemicmedium
AT blagosklonnymv rapamycinreversesinsulinresistanceirinhighglucosemediumwithoutcausingirinnormoglycemicmedium